[HTML][HTML] Aberrantly elevated Bmi1 promotes cervical cancer tumorigenicity and tumor sphere formation via enhanced transcriptional regulation of Sox2 genes
R Xu, L Chen, WT Yang - Oncology Reports, 2019 - spandidos-publications.com
The exact molecular mechanisms underlying cervical tumorigenesis are poorly understood.
Polycomb complex protein Bmi1 (Bmi1) is involved in the malignant transformation and …
Polycomb complex protein Bmi1 (Bmi1) is involved in the malignant transformation and …
Overexpression of Bmi-1 in uterine cervical cancer: correlation with clinicopathology and prognosis
X Zhang, CX Wang, C Zhu, J Zhang, S Kan… - International Journal of …, 2010 - ijgc.bmj.com
Introduction: B-cell-specific Moloney murine leukemia virus integration site 1 (Bmi-1) is a
member of polycomb group, which participates in axial patterning, hematopoiesis, cell cycle …
member of polycomb group, which participates in axial patterning, hematopoiesis, cell cycle …
Overexpression of polycomb protein BMI-1 in human specimens of breast, ovarian, endometrial and cervical cancer
A Honig, C Weidler, S Häusler… - Anticancer …, 2010 - ar.iiarjournals.org
Introduction: The polycomb group (PcG) proteins form chromatin-modifying complexes that
are commonly deregulated in cancer. The PcG protein BMI-I is overexpressed by various …
are commonly deregulated in cancer. The PcG protein BMI-I is overexpressed by various …
Overexpression of BMI‐1 is associated with poor prognosis in cervical cancer
YQ Tong, B Liu, HY Zheng, YJ He… - Asia‐Pacific Journal …, 2012 - Wiley Online Library
Aim It has been reported that BMI‐1, a gene transcription promoter overexpressed in various
human cancers, is associated with poor survival. We investigated whether BMI‐1 is a marker …
human cancers, is associated with poor survival. We investigated whether BMI‐1 is a marker …
[HTML][HTML] Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival
Bmi-1 is a polycomb group protein that was identified as c-myc cooperating oncogene in
murine lymphomagenesis. The current study was undertaken to determine the role of Bmi-1 …
murine lymphomagenesis. The current study was undertaken to determine the role of Bmi-1 …
Expression of bmi-1 protein in cervical, breast and ovarian cancer
MM Gavrilescu, AM Todosi, MG ANITEI… - The Medical-Surgical …, 2012 - revmedchir.ro
B-cell-specific Moloney murine leukemia virus integration site 1 (Bmi-1) is a member of
polycomb group, which participates in axial patterning, hematopoiesis, cell cycle regulation …
polycomb group, which participates in axial patterning, hematopoiesis, cell cycle regulation …
[HTML][HTML] BMI‑1, a promising therapeutic target for human cancer
MC Wang, CL Li, J Cui, M Jiao, T Wu… - Oncology …, 2015 - spandidos-publications.com
BMI‑1 oncogene is a member of the polycomb‑group gene family and a transcriptional
repressor. Overexpression of BMI‑1 has been identified in various human cancer tissues …
repressor. Overexpression of BMI‑1 has been identified in various human cancer tissues …
[HTML][HTML] Deletion analysis of BMI1 oncoprotein identifies its negative regulatory domain
Abstract Background The polycomb group (PcG) protein BMI1 is an important regulator of
development. Additionally, aberrant expression of BMI1 has been linked to cancer stem cell …
development. Additionally, aberrant expression of BMI1 has been linked to cancer stem cell …
Bmi‐1 is critical for the proliferation and invasiveness of gastric carcinoma cells
W Li, Y Li, Y Tan, K Ma, J Cui - Journal of gastroenterology and …, 2010 - Wiley Online Library
Abstract Background and Aim: Bmi‐1 is a transcriptional repressor belonging to the
Polycomb group and is associated with the cell proliferation and carcinogenesis of a variety …
Polycomb group and is associated with the cell proliferation and carcinogenesis of a variety …
Polycomb protein BMI-1 as a potential therapeutic target in mucinous ovarian cancer
S Abobaker, H Kulbe, ET Taube… - Anticancer …, 2022 - ar.iiarjournals.org
Background/Aim: Mucinous ovarian carcinoma (mOC) is a rare subtype with distinct clinical
characteristics and biological behavior that differentiate them from other epithelial ovarian …
characteristics and biological behavior that differentiate them from other epithelial ovarian …